Rezetecan (SHR9265) is a topoisomerase I inhibitor. In addition, Rezetecan can be used to synthesize Trastuzumab rezetecan, an antineoplastic agent. Rezetecan can be used as a cytotoxic payload (ADC Cytotoxin) in antibody-drug conjugates (ADCs)[1][2].
Molecular Weight:
1195.27
Purity:
99.60
Formula:
C58H67FN10O15S
Target:
ADC Payload,Topoisomerase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
